Neurocrine Biosciences NBIX
NASDAQ NBIX
$143.29 +1.98 (+1.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Ending Cash Balance (2015 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Ending Cash Balance (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.03 Bn
10 Neurocrine Biosciences 14.41 Bn 10.11 Bn 935.80 Mn 338.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 338.90 Mn
Mar 31, 2026 274.50 Mn
Dec 31, 2025 721.00 Mn
Sep 30, 2025 348.20 Mn
Jun 30, 2025 272.00 Mn
Mar 31, 2025 202.10 Mn
Dec 31, 2024 241.00 Mn
Sep 30, 2024 357.10 Mn
Jun 30, 2024 147.70 Mn
Mar 31, 2024 404.30 Mn
Dec 31, 2023 259.10 Mn
Sep 30, 2023 301.70 Mn
Jun 30, 2023 168.20 Mn
Mar 31, 2023 111.60 Mn
Dec 31, 2022 270.70 Mn
Sep 30, 2022 220.00 Mn
Jun 30, 2022 171.10 Mn
Mar 31, 2022 278.00 Mn
Dec 31, 2021 344.00 Mn
Sep 30, 2021 314.30 Mn
API Access

Neurocrine Biosciences Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=NBIX&period=max&api_key=YOUR_API_KEY